Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3146 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31578 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-31 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-315 |
filingDate |
2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3090f9cd92ebf781ba9ddd95170504ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb2efaee0f8da9069da293659fa5349c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ca69aa9d04608ae820c785231c9214 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d608546cbaabb5232ef9bffd1ba44811 |
publicationDate |
2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9962494-B2 |
titleOfInvention |
Drug delivery device with end of dose feedback |
abstract |
A method and an assembly for providing a drug delivery device is presented. The assembly includes a housing and an end of dose feedback connection provides the user with an audible and/or tactile signal to indicate that the drug delivery is completed. A first section of the end of dose feedback connection is located on a distal portion of an inner sleeve and a second section of the end of dose feedback connection is located on the mid-body. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D909570-S |
priorityDate |
2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |